Healwell AI Past Earnings Performance

Past criteria checks 0/6

Healwell AI's earnings have been declining at an average annual rate of -54.2%, while the Healthcare industry saw earnings growing at 0.3% annually. Revenues have been declining at an average rate of 7.3% per year.

Key information

-54.2%

Earnings growth rate

-52.1%

EPS growth rate

Healthcare Industry Growth-6.7%
Revenue growth rate-7.3%
Return on equity-149.7%
Net Margin-440.0%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

Healwell AI Inc. (TSE:AIDX) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

Mar 11
Healwell AI Inc. (TSE:AIDX) Stock Rockets 33% As Investors Are Less Pessimistic Than Expected

MCI Onehealth Technologies Inc.'s (TSE:DRDR) Stock Retreats 57% But Revenues Haven't Escaped The Attention Of Investors

Apr 17
MCI Onehealth Technologies Inc.'s (TSE:DRDR) Stock Retreats 57% But Revenues Haven't Escaped The Attention Of Investors

Revenue & Expenses Breakdown
Beta

How Healwell AI makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TSX:AIDX Revenue, expenses and earnings (CAD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 237-32145
30 Sep 2352-31316
30 Jun 2351-32297
31 Mar 2353-24298
31 Dec 2210-18148
30 Sep 2224-21235
30 Jun 2234-17274
31 Mar 2241-17312
31 Dec 2148-16330
30 Sep 2145-13291
30 Jun 2142-6270
31 Mar 2138-3210
31 Dec 2039-1170
30 Sep 20401100
31 Dec 1946060
31 Dec 1845060
31 Dec 1744050

Quality Earnings: AIDX is currently unprofitable.

Growing Profit Margin: AIDX is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: AIDX is unprofitable, and losses have increased over the past 5 years at a rate of 54.2% per year.

Accelerating Growth: Unable to compare AIDX's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: AIDX is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (6.7%).


Return on Equity

High ROE: AIDX has a negative Return on Equity (-149.74%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.